Dr. Martin S. Weber

Name Card

Main Affiliation
 
Staff Status
unigoe
 

1-30 of 30
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2023 | Journal Article | Overview
    ​ ​Dybowski S, Torke S, Weber MS. ​Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors: A Review​. ​​JAMA Neurology. ​2023;. ​doi:10.1001/jamaneurol.2022.5332. 
    ​Details  DOI  PMID  PMC 
  • 2022 | Journal Article | 
    ​ ​Geladaris A, Torke S, Weber MS. ​Bruton’s Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?​. ​​CNS Drugs. ​2022;​36​(10):​​1019​-1030​. ​doi:10.1007/s40263-022-00951-z. 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Weber MS, Nicholas JA, Yeaman MR. ​Balancing Potential Benefits and Risks of Bruton Tyrosine Kinase Inhibitor Therapies in Multiple Sclerosis During the COVID-19 Pandemic​. ​​Neurology - Neuroimmunology Neuroinflammation. ​2021;​8​(6):​​e1067​. ​doi:10.1212/NXI.0000000000001067. 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Sellebjerg F, Weber MS. ​Targeting B cells in multiple sclerosis​. ​​Current Opinion in Neurology. ​2021;​34​(3):​​295​-302​. ​doi:10.1097/WCO.0000000000000938. 
    ​Details  DOI 
  • 2021 | Journal Article | Research Paper | 
    ​ ​Traub J, Husseini L, Weber MS. ​B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders​. ​​Pharmaceuticals. ​2021;​14​(1):​​37​. ​doi:10.3390/ph14010037. 
    ​Details  DOI 
  • 2021 | Journal Article | 
    ​ ​Maass F, von Gottberg P, Franz J, Stadelmann C, Bähr M, Weber MS. ​Case Report: Findings Suggestive of Paraclinical Progressive Multifocal Leukoencephalopathy and Lung Cancer-Derived Brain Metastases in an MS Patient Treated With Fingolimod​. ​​Frontiers in Neurology. ​2021;​12​. ​doi:10.3389/fneur.2021.561158. 
    ​Details  DOI 
  • 2021 | Journal Article | Research Paper | 
    ​ ​Bergner CG, Genc N, Hametner S, Franz J, Mitkovski M, Weber MS, et al. ​Concurrent axon and myelin destruction differentiates X‐linked adrenoleukodystrophy from multiple sclerosis​. ​​Glia. ​2021;​69​(10):​​2362​-2377​. ​doi:10.1002/glia.24042. 
    ​Details  DOI  PMID  PMC 
  • 2021 | Journal Article | Research Paper
    ​ ​Fernandez Garcia-Agudo L, Steixner-Kumar AA, Curto Y, Barnkothe N, Hassouna I, Jähne S, et al. ​Brain erythropoietin fine-tunes a counterbalance between neurodifferentiation and microglia in the adult hippocampus​. ​​Cell Reports. ​2021;​36​(8):​​109548​. ​doi:10.1016/j.celrep.2021.109548. 
    ​Details  DOI  PMID  PMC 
  • 2020 | Journal Article
    ​ ​Häusler D, Hajiyeva Z, Traub JW, Zamvil SS, Lalive PH, Brück W, et al. ​Glatiramer acetate immune modulates B-cell antigen presentation in treatment of MS​. ​​Neurology - Neuroimmunology Neuroinflammation. ​2020;​7​(3):​​e698​. ​doi:10.1212/NXI.0000000000000698. 
    ​Details  DOI 
  • 2020 | Journal Article | Editorial Contribution (Editorial, Introduction, Epilogue)
    ​ ​Rommer PS, Weber MS, Illes Z, Zettl UK. ​Editorial: Multiple Sclerosis – From Bench to Bedside: Currents Insights Into Pathophysiological Concepts and Their Potential Impact on Patients​. ​​Frontiers in Immunology. ​2020;​11​. ​doi:10.3389/fimmu.2020.00137. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Kümpfel T, Thiel S, Meinl I, Ciplea AI, Bayas A, Hoffmann F, et al. ​Anti-CD20 therapies and pregnancy in neuroimmunologic disorders​. ​​Neurology - Neuroimmunology Neuroinflammation. ​2020;​8​(1):​​e913​. ​doi:10.1212/NXI.0000000000000913. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Torke S, Weber MS. ​Inhibition of Bruton´s tyrosine kinase as a novel therapeutic approach in multiple sclerosis​. ​​Expert Opinion on Investigational Drugs. ​2020;​29​(10):​​1143​-1150​. ​doi:10.1080/13543784.2020.1807934. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Nissimov N, Hajiyeva Z, Torke S, Grondey K, Brück W, Häusser-Kinzel S, et al. ​B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis​. ​​Proceedings of the National Academy of Sciences. ​2020;​117​(41):​​25690​-25699​. ​doi:10.1073/pnas.2012249117. 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Ringelstein M, Harmel J, Zimmermann H, Brandt AU, Paul F, Haarmann A, et al. ​Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders​. ​​Neurology. ​2020;​94​(4):​​e407​-e418​. ​doi:10.1212/WNL.0000000000008684. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Jarius S, Pellkofer H, Siebert N, Korporal-Kuhnke M, Hümmert MW, Ringelstein M, et al. ​Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients​. ​​Journal of Neuroinflammation. ​2020;​17​(1). ​doi:10.1186/s12974-020-01824-2. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Traub J, Häusser-Kinzel S, Weber M. ​Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients​. ​​International Journal of Molecular Sciences. ​2020;​21​(14):​​5021​. ​doi:10.3390/ijms21145021. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Häusler D, Torke S, Weber MS. ​High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease​. ​​Frontiers in Immunology. ​2020;​11​. ​doi:10.3389/fimmu.2020.00301. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Torke S, Pretzsch R, Häusler D, Haselmayer P, Grenningloh R, Boschert U, et al. ​Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease​. ​​Acta Neuropathologica. ​2020;​140​(4):​​535​-548​. ​doi:10.1007/s00401-020-02204-z. 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Lieschke S, Zechmeister B, Haupt M, Zheng X, Jin F, Hein K, et al. ​CCL11 Differentially Affects Post-Stroke Brain Injury and Neuroregeneration in Mice Depending on Age​. ​​Cells. ​2020;​9​(1):​​66​. ​doi:10.3390/cells9010066. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Bittner S, Engel S, Lange C, Weber MS, Haghikia A, Luessi F, et al. ​Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : Current status and recommendations in Germany​. ​​Der Nervenarzt. ​2019;​90​(12):​​1245-1253​-1253​. ​doi:10.1007/s00115-019-0760-0. 
    ​Details  DOI  PMID  PMC 
  • 2019 | Journal Article
    ​ ​Garcia-Agudo LF, Janova H, Sendler LE, Arinrad S, Steixner AA, Hassouna I, et al. ​Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion​. ​​The FASEB Journal. ​2019;​33​(7):​​8634​-8647​. ​doi:10.1096/fj.201900337R. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Häusler D, Torke S, Peelen E, Bertsch T, Weber M, Heilmann M, et al. ​Reply: Neither human nor mouse is hypercalcaemic with 250 nmol/l 25-hydroxyvitamin D​. ​​Brain: A Journal of Neurology. ​2019;​143​(2):​​e10​-e10​. ​doi:10.1093/brain/awz389. 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Montalban X, Arnold D, Weber M, Staikov I, Piasecka-Stryczynska K, Gillett A, et al. ​056 Efficacy and safety of the Bruton’s tyrosine kinase inhibitor evobrutinib (M2951) in patients with relapsing multiple sclerosis over 48 weeks: a randomized, placebo-controlled, phase 2 study​. ​​Journal of Neurology, Neurosurgery & Psychiatry. ​2019;​90​(e7):​​A18.2​-A19​. ​doi:10.1136/jnnp-2019-anzan.49. 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, et al. ​Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis​. ​​JCI Insight. ​2019;. ​doi:10.1172/jci.insight.126599. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Weber MS, Derfuss T, Metz I, Brück W. ​Defining distinct features of anti-MOG antibody associated central nervous system demyelination​. ​​Therapeutic Advances in Neurological Disorders. ​2018;​11​:​​175628641876208​. ​doi:10.1177/1756286418762083. 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Faissner S, Weber M. ​Aktuelles aus der Forschung​. ​​Aktuelle Neurologie. ​2018;​45​(09):​​690​-691​. ​doi:10.1055/a-0664-6010. 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Faissner S, Weber M. ​Aktuelles aus der Forschung​. ​​Aktuelle Neurologie. ​2017;​44​(07):​​510​-512​. ​doi:10.1055/s-0043-110327. 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Janova H, Böttcher C, Holtman IR, Regen T, Rossum D, Götz A, et al. ​CD14 is a key organizer of microglial responses to CNS infection and injury​. ​​Glia. ​2016;​64​(4):​​635​-649​. ​doi:10.1002/glia.22955. 
    ​Details  DOI  PMID  PMC 
  • 2016 | Journal Article
    ​ ​Klotz L, Berthele A, Brück W, Chan A, Flachenecker P, Gold R, et al. ​Monitoring of blood parameters under course-modified MS therapy. Substance-specific relevance and current recommendations for action​. ​​Der Nervenarzt. ​2016;​87​(6):​​645​-659​. ​doi:10.1007/s00115-016-0077-1. 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article
    ​ ​Kowarik MC, Grummel V, Wemlinger S, Buck D, Weber MS, Berthele A, et al. ​Immune cell subtyping in the cerebrospinal fluid of patients with neurological diseases​. ​​Journal of Neurology. ​2014;​261​(1):​​130​-143​. ​doi:10.1007/s00415-013-7145-2. 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Project

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp00783
ID: 0000000
PREF: vancouver TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.